Key2Brain is a Swedish biotechnology company dedicated to developing next generation brain targeting therapies utilizing its proprietary blood-brain barrier-crossing technology. The technology enables efficient brain uptake and broad distribution into the brain and can be integrated into a wide range of therapeutic molecules. The pipeline is being developed internally and in partnerships where Key2Brain’s team leverages extensive industry experience in biologics and brain-targeting drugs, accelerating the translation from discovery to the clinic.

Key2Brain AB

The Stockholm office focuses on advanced scientific research and technological innovation in biotechnology and pharmaceuticals.

Key2Brain AB

Org chart

Teams

Offices

Key2Brain AB

Org chart

Teams

Offices

Related companies